Tag: Cancer: Prostate
MRI Feasible for Predicting Prostate CA in Unselected Sample
Adjusted odds ratio of prostate cancer significantly higher for MRI score than PSA
DNA-Repair Gene Mutations ID’d in Metastatic Prostate Cancer
Prevalence of 11.8 percent for germline DNA-repair gene mutations presumed to be deleterious
Docs Tending Away From Post-Prostatectomy Adjuvant RT
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
Benefits for Robotic-Assisted Laparoscopic Prostatectomy
Reduced risk of positive surgical margins versus open prostatectomy for patients with pT2 disease only
Prostate Cancer Diagnoses Down From 2011 to 2013
Use of active surveillance increasing, active treatment decreasing for low-risk disease
ADT Plus Radiotherapy Ups Survival in Metastatic Prostate CA
Superior median, five-year OS for prostate RT plus ADT versus ADT alone in propensity score analyses
PSA Cut Point of ≥0.4 ng/mL Predicts Progression
Shows the strongest correlation between biochemical recurrence and subsequent systemic progression
Tasquinimod Improves Radiographic PFS in mCRPC
Does not improve overall survival in metastatic castration-resistant prostate cancer
Midlife PSA Levels Predict Future Lethal Prostate Cancer
PSA levels in midlife strongly predict future lethal prostate cancer risk in U.S. cohort
SBRT, Proton Beam Therapy Use Increasing for Prostate CA
Median cost of stereotactic body radiotherapy lower than IMRT or proton beam therapy
